Regulators in the U.S. and the European Union agreed to review Biogen’s applications for approval of a higher dose Spinraza ...

U.S. to incorporate NaviLens technology on its packaging and will be featured on the all® free clear MIGHTY PACS® Original ...

Applications are based on data from the DEVOTE study, which demonstrate the potential for the investigational higher dose ...

In December 2024, the Child's Rights Bureau of the Federal Ministry of Information and National Orientation in collaboration with the United Nations Children's Fund UNICEF convened a media dialogue in ...

The US Food and Drug Administration (FDA) has accepted Biogen’s supplemental New Drug Application (sNDA) and the European ...

CAMBRIDGE, Mass. - Biogen Inc. (NASDAQ:BIIB), a $20.8 billion biotechnology company with a robust 75.6% gross profit margin, ...

Wolsong Unit 2 discharges 29 tons of radioactive waste into ocean, investigation underway Nuclear watchdog launches inquiry ...

In a good-news-bad-news week for Biogen, the company will cut an undisclosed number of employees, just as a higher dose of ...

The pharmaceutical industry’s shift towards advanced secondary packaging is fueled by the need to ensure drug integrity and ...

Detailed price information for Rapid Dose Therapeutics Corp (RDTCF) from The Globe and Mail including charting and trades.

The suspect accused in the fiery death of a woman in a locked storage unit plans to fight the charges against her, her ...